Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Traian Sulea

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Plos One|July 28, 2017
Assisted Design of Antibody and Protein Therapeutics (ADAPT)Victor Vivcharuk, Jason Baardsnes, Christophe Deprez, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 29, 2020
Serum albumin-binding V<sub>H</sub> Hs with variable pH sensitivities enable tailored half-life extension of biologicsHenk van Faassen, Shannon Ryan, Kevin A Henry, et al.
Frontiers in Immunology|August 8, 2022
Programmable Attenuation of Antigenic Sensitivity for a Nanobody-Based EGFR Chimeric Antigen Receptor Through Hinge Domain TruncationScott McComb, Tina Nguyen, Alex Shepherd, et al.
Mabs|November 29, 2019
Structure-based engineering of pH-dependent antibody binding for selective targeting of solid-tumor microenvironmentTraian Sulea, Nazanin Rohani, Jason Baardsnes, et al.
Frontiers in Oncology|November 12, 2025
Engineered multifunctional transforming growth factor-β type II receptor ectodomain fusions for oncology applicationsAnne E G Lenferink, John C Zwaagstra, Jason Baardsnes, et al.
Mabs|July 19, 2019
Binding symmetry and surface flexibility mediate antibody self-associationJoseph D Schrag, Marie-Ève Picard, Francis Gaudreault, et al.
Antimicrobial Agents and Chemotherapy|October 1, 2014
Small-molecule inhibitors of the pseudaminic acid biosynthetic pathway: targeting motility as a key bacterial virulence factorRobert Ménard, Ian C Schoenhofen, Limei Tao, et al.
Biochemistry|March 19, 2003
Specificity determinants of human cathepsin s revealed by crystal structures of complexesThomas A Pauly, Traian Sulea, Mark Ammirati, et al.
Molecular Cancer Therapeutics|May 8, 2012
Engineering and therapeutic application of single-chain bivalent TGF-β family trapsJohn C Zwaagstra, Traian Sulea, Jason Baardsnes, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2026
Multifunctional ACE2-nanobody fusion design for pan-specific neutralization and cardiovascular protection in SARS coronavirus infectionTraian Sulea, Matthew Stuible, Maria Moreno, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Plos One|July 28, 2017
Assisted Design of Antibody and Protein Therapeutics (ADAPT)Victor Vivcharuk, Jason Baardsnes, Christophe Deprez, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 29, 2020
Serum albumin-binding V<sub>H</sub> Hs with variable pH sensitivities enable tailored half-life extension of biologicsHenk van Faassen, Shannon Ryan, Kevin A Henry, et al.
Frontiers in Immunology|August 8, 2022
Programmable Attenuation of Antigenic Sensitivity for a Nanobody-Based EGFR Chimeric Antigen Receptor Through Hinge Domain TruncationScott McComb, Tina Nguyen, Alex Shepherd, et al.
Mabs|November 29, 2019
Structure-based engineering of pH-dependent antibody binding for selective targeting of solid-tumor microenvironmentTraian Sulea, Nazanin Rohani, Jason Baardsnes, et al.
Frontiers in Oncology|November 12, 2025
Engineered multifunctional transforming growth factor-β type II receptor ectodomain fusions for oncology applicationsAnne E G Lenferink, John C Zwaagstra, Jason Baardsnes, et al.
Mabs|July 19, 2019
Binding symmetry and surface flexibility mediate antibody self-associationJoseph D Schrag, Marie-Ève Picard, Francis Gaudreault, et al.
Antimicrobial Agents and Chemotherapy|October 1, 2014
Small-molecule inhibitors of the pseudaminic acid biosynthetic pathway: targeting motility as a key bacterial virulence factorRobert Ménard, Ian C Schoenhofen, Limei Tao, et al.
Biochemistry|March 19, 2003
Specificity determinants of human cathepsin s revealed by crystal structures of complexesThomas A Pauly, Traian Sulea, Mark Ammirati, et al.
Molecular Cancer Therapeutics|May 8, 2012
Engineering and therapeutic application of single-chain bivalent TGF-β family trapsJohn C Zwaagstra, Traian Sulea, Jason Baardsnes, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2026
Multifunctional ACE2-nanobody fusion design for pan-specific neutralization and cardiovascular protection in SARS coronavirus infectionTraian Sulea, Matthew Stuible, Maria Moreno, et al.
Pageof 10